tiprankstipranks
Advertisement
Advertisement

PCTUBUL Stock Latest News

Tubulis – Weekly Recap
Private CompaniesTubulis – Weekly Recap
10d ago
TUBUL
Tubulis Lead ADC TUB-040 Set for Phase I/IIa Data Presentation at ASCO 2026
PremiumPrivate Companies
Tubulis Lead ADC TUB-040 Set for Phase I/IIa Data Presentation at ASCO 2026
14d ago
TUBUL
Tubulis Highlights Upcoming ASCO 2026 Data Update for Lead ADC TUB-040
PremiumPrivate Companies
Tubulis Highlights Upcoming ASCO 2026 Data Update for Lead ADC TUB-040
14d ago
TUBUL
Tubulis Highlights Alco5 Conjugation Platform at Therapeutic Frontiers in Medicine 2026
PremiumPrivate Companies
Tubulis Highlights Alco5 Conjugation Platform at Therapeutic Frontiers in Medicine 2026
26d ago
TUBUL
Tubulis Showcases Alco5 Conjugation Platform at Therapeutic Frontiers in Medicine 2026
PremiumPrivate Companies
Tubulis Showcases Alco5 Conjugation Platform at Therapeutic Frontiers in Medicine 2026
26d ago
TUBUL
Gilead to Acquire Tubulis in $5 Billion Antibody-Drug Conjugate Deal
PremiumPrivate CompaniesGilead to Acquire Tubulis in $5 Billion Antibody-Drug Conjugate Deal
28d ago
TUBUL
Gilead to Acquire Tubulis in $5 Billion Antibody-Drug Conjugate Deal
Premium
Private Companies
Gilead to Acquire Tubulis in $5 Billion Antibody-Drug Conjugate Deal
28d ago
TUBUL
Tubulis Highlights ADC Linker Technology at Gynecologic Oncology Summit
Premium
Private Companies
Tubulis Highlights ADC Linker Technology at Gynecologic Oncology Summit
1M ago
TUBUL
Scientific Leadership at Tubulis Recognized With Friedrich-Stolz Award 2026
PremiumPrivate Companies
Scientific Leadership at Tubulis Recognized With Friedrich-Stolz Award 2026
1M ago
TUBUL
Tubulis Showcases ADC Linker Technology at Global Gynecologic Oncology Summit
PremiumPrivate Companies
Tubulis Showcases ADC Linker Technology at Global Gynecologic Oncology Summit
1M ago
TUBUL
Scientific Recognition Highlights Tubulis Leadership in ADC Innovation
PremiumPrivate Companies
Scientific Recognition Highlights Tubulis Leadership in ADC Innovation
1M ago
TUBUL
Tubulis Leadership to Present Journey and Strategy at LSX Europe Congress
PremiumPrivate Companies
Tubulis Leadership to Present Journey and Strategy at LSX Europe Congress
1M ago
TUBUL
Tubulis Showcases ADC Strategy and Growth Milestones at LSX Europe Congress
PremiumPrivate CompaniesTubulis Showcases ADC Strategy and Growth Milestones at LSX Europe Congress
1M ago
TUBUL
Tubulis Highlights Targeted Conjugate Platform at Novel Conjugate Summit 2026
Premium
Private Companies
Tubulis Highlights Targeted Conjugate Platform at Novel Conjugate Summit 2026
2M ago
TUBUL
Tubulis Showcases Conjugation Technologies at Novel Conjugate Summit 2026
Premium
Private Companies
Tubulis Showcases Conjugation Technologies at Novel Conjugate Summit 2026
2M ago
TUBUL
Tubulis Highlights Early-Stage TUB-040 Clinical Data at Major Oncology Congress
PremiumPrivate Companies
Tubulis Highlights Early-Stage TUB-040 Clinical Data at Major Oncology Congress
2M ago
TUBUL
Tubulis Showcases TUB-040 Clinical Progress in Ovarian Cancer at ESGO 2026
PremiumPrivate Companies
Tubulis Showcases TUB-040 Clinical Progress in Ovarian Cancer at ESGO 2026
2M ago
TUBUL
Tubulis Highlights Clinical-Stage ADC TUB-040 at Major European Oncology Congress
PremiumPrivate Companies
Tubulis Highlights Clinical-Stage ADC TUB-040 at Major European Oncology Congress
2M ago
TUBUL
Tubulis Highlights Phase 1/2 Clinical Progress for TUB-040 at Major ESGO Oncology Meeting
PremiumPrivate Companies
Tubulis Highlights Phase 1/2 Clinical Progress for TUB-040 at Major ESGO Oncology Meeting
2M ago
TUBUL
Tubulis Highlights Clinical Progress of ADC Candidate TUB-040 at World ADC London
PremiumPrivate CompaniesTubulis Highlights Clinical Progress of ADC Candidate TUB-040 at World ADC London
3M ago
TUBUL
Tubulis Adds Veteran Oncologist Steve Kelsey to Board as Lead ADC Programs Advance
Premium
Private Companies
Tubulis Adds Veteran Oncologist Steve Kelsey to Board as Lead ADC Programs Advance
3M ago
TUBUL
Tubulis Gains Scientific Validation as Alco5 ADC Platform Data Published in Nature Communications
Premium
Private Companies
Tubulis Gains Scientific Validation as Alco5 ADC Platform Data Published in Nature Communications
3M ago
TUBUL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >